Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SHPG > SEC Filings for SHPG > Form 8-K/A on 4-Apr-2014All Recent SEC Filings

Show all filings for SHIRE PLC

Form 8-K/A for SHIRE PLC


4-Apr-2014

Financial Statements and Exhibits


Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired

The audited consolidated balance sheets of ViroPharma Incorporated and subsidiaries as of December 31, 2012 and 2011, and the audited consolidated statements of operations, comprehensive income, stockholders' equity and cash flows for the years ended December 31, 2012, 2011 and 2010, and the notes related thereto, are filed herewith as Exhibit 99.3 and incorporated herein by reference.

The unaudited consolidated balance sheet of ViroPharma Incorporated and subsidiaries as of September 30, 2013, and the unaudited consolidated statements of operations and consolidated statements of comprehensive income/(loss), stockholders' equity and cash flows for the nine months ended September 30, 2013 and 2012, and the notes related thereto, are filed herewith as Exhibit 99.4 and incorporated herein by reference.

(b) Pro Forma Financial Information

Shire and ViroPharma's unaudited pro forma condensed combined financial information as of and for the year ended December 31, 2013, is filed herewith as Exhibit 99.2 and incorporated herein by reference.

(d) Exhibits

The following exhibits are filed as part of the current report:

Exhibit No.   Description

23.1          Consent of KPMG LLP, independent registered public accounting firm
              to ViroPharma Incorporated

99.2          Shire and ViroPharma's unaudited pro forma condensed combined
              financial information as of and for the year ended December 31, 2013

99.3          ViroPharma Incorporated and subsidiaries' audited consolidated
              balance sheets as of December 31, 2012 and 2011, and audited
              consolidated statements of operations, comprehensive income,
              stockholders' equity and cash flows for the years ended December 31,
              2012, 2011 and 2010, and the notes related thereto

99.4          ViroPharma Incorporated and subsidiaries' unaudited consolidated
              balance sheet as of September 30, 2013, and unaudited consolidated
              statements of operations and consolidated statements of
              comprehensive income/(loss), stockholders' equity and cash flows for
              the nine months ended September 30, 2013 and 2012, and the notes
              related thereto


  Add SHPG to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SHPG - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.